Fmoc-Cys(Trt)-OH

• CAT Number: I027663
• CAS Number: 103213-32-7
• Molecular Formula: C37H31NO4S
• Molecular Weight: 585.72
• Purity: 98%
• Synonyms: Fmoc-Cys(Trt)-OH; Fmoc Cys(Trt)-OH; Fmoc-Cys(Trt) OH; Fmoc Cys(Trt) OH
• Solubility: Soluble in DMSO
• Appearance: Solid powder
• Storage: 2-8°C
• IUPAC Name: N-(((9H-fluoren-9-yl)methoxy)carbonyl)-S-trityl-L-cysteine
• InChI: InChI=1S/C37H31NO4S/c39-35(40)34(38-36(41)42-24-33-31-22-12-10-20-29(31)30-21-11-13-23-32(30)33)25-43-37(26-14-4-1-5-15-26,27-16-6-2-7-17-27)28-18-8-3-9-19-28/h1-23,33-34H,24-25H2,(H,38,41)(H,39,40)/t34-/m0/s1
• InChIKey: KLBPUVPNPAJWHZ-UMSFTDKQSA-N
• SMILES: O=C(N([H])[C@H](C(O)=O)CSC(C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3)OCC4C5=CC=CC=C5C6=CC=CC=C64

Fmoc-S-trityl-L-cysteine（Cat No.:I027663） is an intermediate compound commonly used in organic synthesis for the production of synthetic amino acid derivatives. It finds utility in laboratory research and biochemical production processes. The compound’s Fmoc (9-fluorenylmethyloxycarbonyl) protecting group facilitates the synthesis of peptide and protein analogs by selectively protecting the amino group of cysteine. Fmoc-S-trityl-L-cysteine serves as a valuable tool in peptide synthesis, allowing for the generation of diverse amino acid derivatives for various applications in the field of biochemistry and related disciplines.

Reference

1: Kar A, Mannuthodikayil J, Singh S, Biswas A, Dubey P, Das A, Mandal K. Efficient Chemical Protein Synthesis using Fmoc-Masked N-Terminal Cysteine in Peptide Thioester Segments. Angew Chem Int Ed Engl. 2020 Apr 25. doi: 10.1002/anie.202000491. Epub ahead of print. PMID: 32333711.
2: Shan L, Zhuo X, Zhang F, Dai Y, Zhu G, Yung BC, Fan W, Zhai K, Jacobson O, Kiesewetter DO, Ma Y, Gao G, Chen X. A paclitaxel prodrug with bifunctional folate and albumin binding moieties for both passive and active targeted cancer therapy. Theranostics. 2018 Feb 16;8(7):2018-2030. doi: 10.7150/thno.24382. PMID: 29556370; PMCID: PMC5858514.
3: Lajkó G, Grecsó N, Tóth G, Fülöp F, Lindner W, Ilisz I, Péter A. Liquid and subcritical fluid chromatographic enantioseparation of Nα -Fmoc proteinogenic amino acids on Quinidine-based zwitterionic and anion-exchanger type chiral stationary phases. A comparative study. Chirality. 2017 Jun;29(6):225-238. doi: 10.1002/chir.22700. Epub 2017 Apr 19. PMID: 28422383.
4: Králová P, Fülöpová V, Maloň M, Volná T, Popa I, Soural M. Stereoselective Polymer-Supported Synthesis of Morpholine- and Thiomorpholine-3-carboxylic Acid Derivatives. ACS Comb Sci. 2017 Mar 13;19(3):173-180. doi: 10.1021/acscombsci.6b00178. Epub 2017 Jan 30. PMID: 28085245.
5: Bergeron ZL, Chun JB, Baker MR, Sandall DW, Peigneur S, Yu PY, Thapa P, Milisen JW, Tytgat J, Livett BG, Bingham JP. A ‘conovenomic’ analysis of the milked venom from the mollusk-hunting cone snail Conus textile–the pharmacological importance of post-translational modifications. Peptides. 2013 Nov;49:145-58. doi: 10.1016/j.peptides.2013.09.004. Epub 2013 Sep 18. PMID: 24055806; PMCID: PMC6013274.
6: Dadiboyena S, Nefzi A. Parallel Synthesis of Structurally Diverse Aminobenzimidazole Tethered Sultams and Benzothiazepinones. Tetrahedron Lett. 2012 Dec 19;53(51):6897-6900. doi: 10.1016/j.tetlet.2012.09.135. PMID: 23209332; PMCID: PMC3510662.
7: Góngora-Benítez M, Mendive-Tapia L, Ramos-Tomillero I, Breman AC, Tulla-Puche J, Albericio F. Acid-labile Cys-protecting groups for the Fmoc/tBu strategy: filling the gap. Org Lett. 2012 Nov 2;14(21):5472-5. doi: 10.1021/ol302550p. Epub 2012 Oct 17. PMID: 23075170.
8: Gross CM, Lelièvre D, Woodward CK, Barany G. Preparation of protected peptidyl thioester intermediates for native chemical ligation by Nalpha-9-fluorenylmethoxycarbonyl (Fmoc) chemistry: considerations of side-chain and backbone anchoring strategies, and compatible protection for N-terminal cysteine. J Pept Res. 2005 Mar;65(3):395-410. doi: 10.1111/j.1399-3011.2005.00241.x. PMID: 15787970.
9: Chen L, Jensen KJ, Tejbrant J, Taylor JE, Morgan BA, Barany G. Chemical synthesis and receptor binding of catfish somatostatin: a disulfide-bridged beta-D-Galp-(1–>3)-alpha-D-GalpNAc O-glycopeptide. J Pept Res. 2000 Jan;55(1):81-91. doi: 10.1034/j.1399-3011.2000.00154.x. PMID: 10667864.
10: Barlos K, Gatos D, Hatzi O, Koch N, Koutsogianni S. Synthesis of the very acid-sensitive Fmoc-Cys(Mmt)-OH and its application in solid-phase peptide synthesis. Int J Pept Protein Res. 1996 Mar;47(3):148-53. doi: 10.1111/j.1399-3011.1996.tb01338.x. PMID: 8740963.
11: McCurdy SN. The investigation of Fmoc-cysteine derivatives in solid phase peptide synthesis. Pept Res. 1989 Jan-Feb;2(1):147-52. PMID: 2577698.